Gut microbiome metabolites, molecular mimicry, and species-level variation drive long-term efficacy and adverse event outcomes in lung cancer survivors
Xinyu Liu(Chinese Academy of Medical Sciences & Peking Union Medical College), Jingnan Li(Chinese Academy of Medical Sciences & Peking Union Medical College), Hao Tang(Stanford Health Care), Bo Lü(Chinese Academy of Medical Sciences & Peking Union Medical College), Yan Xu(Chinese Academy of Medical Sciences & Peking Union Medical College), Qingyang Zhou(Chinese Academy of Medical Sciences & Peking Union Medical College), Bei Tan(Chinese Academy of Medical Sciences & Peking Union Medical College), Xinmiao Jia(Chinese Academy of Medical Sciences & Peking Union Medical College), Yanlin Zeng(Chinese Academy of Medical Sciences & Peking Union Medical College), Mengzhao Wang(Chinese Academy of Medical Sciences & Peking Union Medical College), Xiaoxing Gao(Chinese Academy of Medical Sciences & Peking Union Medical College), Minjiang Chen(Chinese Academy of Medical Sciences & Peking Union Medical College)
Cited by 40
Related Papers
Factors Associated With Prolonged Viral RNA Shedding in Patients with Coronavirus Disease 2019 (COVID-19)
|Clinical Infectious Diseases|2020|556
Induction of interleukin-8 preserves the angiogenic response in HIF-1α–deficient colon cancer cells
|Nature Medicine|2005|407
Chinese Consensus Report on Family-Based<i>Helicobacter pylori</i>Infection Control and Management (2021 Edition)
|Gut|2021|183